| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neogenomics, Inc. (NEO) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. NEO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.4K | $2.42M | - | |
| COO | 158.9K | $2.18M | - | |
| VP | 90.5K | $1.24M | - | |
| Dir | 86.1K | $1.18M | -5,307 | |
| CEO | 38.1K | $522.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | Jones Steven C | Executive Vice President | Sell | 230,533 | $12.12 | $2,794,059.96 | -7.7% | |
| May 31, 2018 | Jones Steven C | Executive Vice President | Sell | 169,467 | $11.68 | $1,979,736.32 | -1.8% | |
| May 29, 2018 | Balliet Jennifer | VP And Chief Culture Officer | Sale+OE | 65,000 | $11.66 | $758,100.00 | -51.3% | |
| May 15, 2018 | Balliet Jennifer | VP And Chief Culture Officer | Sale+OE | 13,000 | $11.24 | $146,055.00 | -66.7% | |
| May 10, 2018 | Ross Steven A | CIO | Sale+OE | 81,999 | $10.78 | $883,949.22 | -94.8% | |
| Jul 27, 2017 | Hannah Alison L. | Director | Buy | 20,000 | $9.19 | $183,800.00 | +106.5% | |
| Jun 22, 2017 | Balliet Jennifer | VP And Chief Culture Officer | Sell | 10,723 | $8.49 | $91,038.27 | -100% | |
| Jun 5, 2017 | Ross Steven A | CIO | Sale+OE | 70,833 | $7.76 | $549,389.07 | -38.1% | |
| May 26, 2017 | Balliet Jennifer | VP And Chief Culture Officer | Sell | 3,334 | $7.50 | $25,005.00 | -24.9% | |
| Mar 20, 2017 | Brodie Steven G. | President, Pharma Services | Sell | 50,000 | $7.93 | $396,655.00 | -43.3% |